Bill Details - SB475 (2018)

SB 475 - AS AMENDED BY THE SENATE

 

03/14/2018   0978s

2018 SESSION

18-2826

01/10

 

SENATE BILL 475

 

AN ACT relative to testing for Lyme disease.

 

SPONSORS: Sen. Daniels, Dist 11; Rep. P. Schmidt, Straf. 19; Rep. M. MacKay, Hills. 30; Rep. LeBrun, Hills. 32

 

COMMITTEE: Health and Human Services

 

-----------------------------------------------------------------

 

AMENDED ANALYSIS

 

This bill requires health care providers to provide certain information to persons being tested for Lyme disease for 5 years.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

03/14/2018   0978s 18-2826

01/10

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Eighteen

 

AN ACT relative to testing for Lyme disease.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  Statement of Purpose.  

I.  The general court recognizes that:

(a)  Lyme disease is the sixth fastest growing disease in the United States according to the Centers for Disease Control and Prevention.

(b)  Lyme disease is difficult to diagnose and treat.

(c)  Blood tests performed within the first month after initial infection often produce false results.

II.  Therefore, the general court hereby requires health care providers to provide certain information to persons being tested for Lyme disease.

2  New Chapter; Lyme Disease.  Amend RSA by inserting after chapter 141-J the following new chapter:

CHAPTER 141-K

LYME DISEASE

141-K:1  Definitions.  In this chapter:

I.  "Lyme disease" means an infection caused by Borrelia burgdorferi, a type of bacterium called a spirochete that is carried by deer ticks.  An infected tick can transmit the spirochete to the humans and animals it bites.  Untreated, the bacterium travels through the bloodstream, establishes itself in various body tissues, and can cause a number of symptoms, some of which are severe.

II.  "Health care provider" means a person who is duly licensed, certified, authorized, or registered under the laws of the state to provide health care.

141-K:2  Lyme Disease Test Results.

I.  Every health care provider who orders a laboratory test for the presence of Lyme disease shall provide to the patient or his or her legal representative the following written information:

"Your health care provider has ordered a laboratory test for the presence of Lyme disease for you.  Current laboratory testing for Lyme disease can be problematic and standard laboratory tests often result in false negative and false positive results.  If you are tested for Lyme disease, and the results are negative, this does not necessarily mean you do not have Lyme disease.  If you continue to experience symptoms, you should contact your health care provider and inquire about the appropriateness of retesting or additional treatment."

II.  Health care providers shall also provide the detailed test results to the patient or the patient's representative.

III.  A health care provider who provides the notice required under this section shall be immune from civil liability for providing the notice unless the health care provider acts with gross negligence or willful misconduct.

IV.  Health care providers in violation of this chapter shall be subject to disciplinary actions from the appropriate licensing, certifying, or registration authority.

3  Repeal.  RSA 141-K, relative to Lyme disease, is repealed.

4  Effective Date.

I.  Section 3 of this act shall take effect July 1, 2023.

II.  The remainder of this act shall take effect upon its passage.

Docket

Date Status
Jan. 3, 2018 To Be Introduced 01/03/2018 and Referred to Health and Human Services; SJ 1
Jan. 24, 2018 Hearing: 01/24/2018, Room 101, LOB, 01:15 pm; SC 4
March 8, 2018 Committee Report: Ought to Pass with Amendment # 2018-0978s, 03/08/2018; SC 10A
March 8, 2018 Special Order to the next session, Without Objection, MA; 03/08/2018; SJ 6
March 14, 2018 Committee Report: Ought to Pass with Amendment # 2018-0978s, 03/14/2018; SC 11
March 14, 2018 Committee Amendment # 2018-0978s, AA, VV; 03/14/2018; SJ 7
March 14, 2018 Sen. Daniels Moved Laid on Table, MA, VV; 03/14/2018; SJ 7
March 14, 2018 Pending Motion Ought to Pass with Amendment #2018-0978s; 03/14/2018; SJ 7
March 14, 2018 Sen. Daniels Moved to Remove From Table, MA, VV; 03/14/2018; SJ 7
March 14, 2018 Ought to Pass with Amendment 2018-0978s, MA, VV; OT3rdg; 03/14/2018; SJ 7
March 15, 2018 Introduced 03/15/2018 and referred to Health, Human Services and Elderly Affairs HJ 8 P. 70
April 10, 2018 Public Hearing: 04/10/2018 11:00 AM LOB 205
April 17, 2018 Executive Session: 04/17/2018 10:00 AM LOB 205
Committee Report: Refer for Interim Study (Vote 22-1; CC)
April 26, 2018 Committee Report: Refer for Interim Study for 04/26/2018 (Vote 22-1; CC) HC 16 P. 6
April 26, 2018 Refer for Interim Study: MA VV 04/26/2018

Action Dates

Date Body Type
Jan. 24, 2018 Senate Hearing
March 8, 2018 Senate Floor Vote
March 8, 2018 Senate Floor Vote
March 14, 2018 Senate Floor Vote
April 10, 2018 House Hearing
April 17, 2018 House Exec Session

Bill Text Revisions

SB475 Revision: 2825 Date: Dec. 20, 2017, 1:15 p.m.
SB475 Revision: 3266 Date: March 14, 2018, 4:37 p.m.